Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery.

Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery.

Item
http://www.wikidata.org/entity/Q38185970
Cell death and autophagy in tuberculosisThe human immunodeficiency virus protease inhibitor ritonavir is potentially active against urological malignancies.Nanoparticle formulation of ormeloxifene for pancreatic cancerDiabetes Pharmacotherapies and Bladder Cancer: A Medicare Epidemiologic StudySirolimus and metformin synergistically inhibit hepatocellular carcinoma cell proliferation and improve long-term survival in patients with HCC related to hepatitis B virus induced cirrhosis after liver transplantation.Metformin: A Hopeful Promise in Aging Research.HLA Genotyping using Next Generation Sequencing.Metformin pharmacogenomics: a genome-wide association study to identify genetic and epigenetic biomarkers involved in metformin anticancer response using human lymphoblastoid cell lines.The p53 family orchestrates the regulation of metabolism: physiological regulation and implications for cancer therapy.Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy.Pilot study of oral metformin in cancer-bearing cats.Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent.Fertility preservation in Hodgkin's lymphoma patients that undergo targeted molecular therapies: an important step forward from the chemotherapy era.RNA interference: new mechanistic and biochemical insights with application in oral cancer therapy.Target Fishing by Cross-Docking to Explain Polypharmacological Effects
P2860

Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery.

Item
http://www.wikidata.org/entity/Q38185970
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery.
@en
type
label
Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery.
@en
prefLabel
Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P921
P356
P1433
P1476
Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P921